Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Katsuda, Takeshi ^a,b   Tsuchiya, Reiko ^c   Kosaka, Nobuyoshi ^a   Yoshioka, Yusuke ^a   Takagaki, Kentaro ^c   Oki, Katsuyuki ^c   Takeshita, Fumitaka ^a   Sakai, Yasuyuki ^b   Kuroda, Masahiko ^d   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

^c SEEMS Inc   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); FLUORESCENT DYE; MEMBRANE METALLOENDOPEPTIDASE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADIPOSE TISSUE; ALZHEIMER DISEASE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; EXOSOME; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ADIPOSE TISSUE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELLS, CULTURED; EXOSOMES; FLUORESCENT DYES; HUMANS; MESENCHYMAL STROMAL CELLS; NEPRILYSIN; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

MLCS; MLOWN;

EID: 84873688339     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01197     Document Type: Article

References (46)

1. Hardy, J. Amyloid, The presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159 (1997).
2. Selkoe, D. J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453 (1998).
3. Iwata, N., Higuchi, M. & Saido, T. C. Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol. Ther. 108, 129-148 (2005). (Pubitemid 41527082)
4. Iwata, N. et al. Metabolic regulation of brain Abeta by neprilysin. Science 292, 1550-1552 (2001). (Pubitemid 32493424)
5. Iwata, N. et al. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150 (2000). (Pubitemid 30082357)
6. Yasojima, K., Akiyama, H., McGeer, E. G. & McGeer, P. L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci. Lett. 297, 97-100 (2001).
7. Miners, J. S., Barua, N., Kehoe, P. G., Gill, S. & Love, S. Ab-degrading enzymes: potential for treatment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 70, 944-959 (2011).
8. Sakaguchi, Y., Sekiya, I., Yagishita, K. & Muneta, T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 52, 2521-2529 (2005). (Pubitemid 41117441)
9. Banas, A. et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46, 219-228 (2007). (Pubitemid 47171939)
10. Chamberlain,G., Fox, J., Ashton, B.&Middleton, J. Concise review:mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739-2749 (2007). (Pubitemid 350127858)
11. Banas, A., Yamamoto, Y., Teratani, T. & Ochiya, T. Stem cell plasticity: learning from hepatogenic differentiation strategies. Dev. Dyn. 236, 3228-3241 (2007). (Pubitemid 350276382)
12. Sadan,O., Melamed, E.&Offen, D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert. Opin. Biol. Ther. 9, 1487-1497 (2009).
13. Jin, H. K., Bae, J. S., Furuya, S. & Carter, J. E. Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways. Cell Prolif. 42, 571-586 (2009).
14. Habisch, H. J. et al. Efficient processing of Alzheimer's disease amyloid-Beta peptides by neuroectodermally converted mesenchymal stem cells. Stem Cells Dev. 19, 629-633 (2010).
15. Lee, J. K. et al. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells. 28, 329-43 (2010).
16. Kil, J., Jin, H. K. & Bae, J. S. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci. Lett. 450, 136-141 (2009).
17. Lee, H. J. et al. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci. Lett. 481, 30-35 (2010).
18. Zilka, N. et al. Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau. Neuroscience 193, 330-337 (2011).
19. Katsuda, T., Kosaka, N., Takeshita, F. & Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics (in press).
20. Théry, C.,Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593 (2009).
21. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007). (Pubitemid 47214727)
22. Taylor, D. D. & Gercel-Taylor, C. Exosomes/microvesicles: mediators of cancerassociated immunosuppressive microenvironments. Semin. Immunopathol. 33, 441-454 (2011).
23. Kosaka, N. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452 (2010).
24. Bruno, S. et al.Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20, 1053-1067 (2009).
25. Lai, R. C. et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4, 214-222 (2010).
26. Miners, J. S., Verbeek, M. M., Rikkert, M. O., Kehoe, P. G. & Love, S. Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid. J. Neurosci. Methods 167, 229-236 (2008). (Pubitemid 350245527)
27. Théry, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3:Unit 3.22 (2006).
28. Taylor, D. D., Zacharias, W. & Gercel-Taylor, C. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol. Biol. 728, 235-246 (2011).
29. Denzer, K., Kleijmeer, M. J., Heijnen, H. F., Stoorvogel, W. & Geuze, H. J. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113, 3365-3374 (2000).
30. Stewart, K. et al. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue. Res. 313, 281-290 (2005). (Pubitemid 37260435)
31. van Niel, G., Porto-Carreiro, I., Simoes, S. & Raposo, G. Exosomes: a common pathway for a specialized function. J. Biochem. 140, 13-21 (2006). (Pubitemid 44433541)
32. Shirotani, K. et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan-and phosphoramidon- sensitive endopeptidases. J. Biol. Chem. 276, 21895-21901 (2001).
33. Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247 (2008). (Pubitemid 351323020)
34. Carlsson, L. et al. Characteristics of human prostasomes isolated from three different sources. Prostate 54, 322-330 (2003). (Pubitemid 36228170)
35. Gatti, J. L., Métayer, S., Belghazi, M., Dacheux, F. & Dacheux, J. L. Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles. Biol. Reprod. 72, 1452-1465 (2005). (Pubitemid 40696088)
36. Conde-Vancells, J. et al. Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics 4, 416-425 (2010).
37. LaFerla, F.M., Green, K. N. & Oddo, S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509 (2007).
38. Keyser, K. A., Beagles, K. E. & Kiem, H. P. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 16, 555-562 (2007). (Pubitemid 351448291)
39. Banas, A. et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26, 2705-2712 (2008).
40. Ahmadian, Kia N. et al. Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue. J. Mol. Neurosci. 44, 178-185 (2011).
41. Ikegame, Y. et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13, 675-685 (2011).
42. Cocucci, E., Racchetti, G. & Meldolesi, J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19, 43-51 (2009).
43. Alvarez-Erviti, L. et al.Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341-345 (2011).
44. Zhuang, X. et al. Zhang HG.Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19, 1769-1779 (2011).
45. Hemming, M. L. et al. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med. 4, e262 (2007).
46. Liu, Y. et al. Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenicmouse model of Alzheimer disease. Mol. Ther. 17, 1381-1386 (2009).